Jazz Pharmaceuticals (JAZZ)
(Real Time Quote from BATS)
$109.58 USD
-1.97 (-1.77%)
Updated Sep 18, 2024 03:55 PM ET
After-Market: $109.56 -0.02 (-0.02%) 4:14 PM ET
3-Hold of 5 3
A Value C Growth D Momentum A VGM
Brokerage Reports
0 items in cart
Jazz Pharmaceuticals PLC [JAZZ]
Reports for Purchase
Showing records 1 - 20 ( 259 total )
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Strong Q2, Strong Business, Weak Valuation; Reiterate Buy and $200 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
INVITE: ET KOL Call - Delving Into The Therapeutic Landscape
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Despite Muddled 1Q, 2024 Guidance Reiterated; Stock Unjustifiably at All-Time Low Multiples; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Stock Reflects Overly Pessimistic Prognosis and Little, If Any, Pipeline Value; Adding Zani For BTC; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department